Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma
2015-01-01 Santoni, M; Conti, A; Porta, C; Procopio, G; Sternberg, Cn; Basso, U; De Giorgi, U; Bracarda, S; Rizzo, M; Ortega, C; Massari, F; Iacovelli, R; Derosa, L; Masini, C; Milella, M; Di Lorenzo, G; Atzori, F; Pagano, M; Buti, S; De Vivo, R; Mosca, A; Rossi, M; Paglino, C; Verzoni, E; Cerbone, L; Muzzonigro, G; Falconi, M; Montironi, R; Burattini, L; Santini, D; Cascinu, S.
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide
2019-01-01 Lolli, C.; De Lisi, D.; Conteduca, V.; Gurioli, G.; Scarpi, E.; Schepisi, G.; Ravaglia, G.; Menna, C.; Farolfi, A.; Altavilla, A.; Burgio, S. L.; Tonini, G.; Santini, D.; De Giorgi, U.
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
2014-01-01 De Giorgi, U; Caroli, P; Burgio, Sl; Menna, C; Conteduca, V; Bianchi, E; Fabbri, F; Carretta, E; Amadori, D; Paganelli, G; Matteucci, F.
High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party
2007-01-01 De Giorgi, U; Blaise, D; Lange, A; Viens, P; Marangolo, M; Madroszyk, A; Brune, M; Afanassiev, Bv; Rosti, G; Demirer, T.
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study
2017-01-01 Oing, C; Oechsle, K; Necchi, A; Loriot, Y; De Giorgi, U; Fléchon, A; Daugaard, G; Fedyanin, M; Faré, E; Bokemeyer, C.
Prevention and therapy of neutropenia in elderly patients
2003-01-01 Rosti, G; Kopf, B; Cariello, A; Monti, M; Dazzi, C; Papiani, G; Giovanis, P; De Giorgi, U; Marangolo, M.
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
2018-01-01 Pal, Sk; Rosenberg, Je; Hoffman-Censits, Jh; Berger, R; Quinn, Di; Galsky, Md; Wolf, J; Dittrich, C; Keam, B; Delord, Jp; Schellens, Jhm; Gravis, G; Medioni, J; Maroto, P; Sriuranpong, V; Charoentum, C; Burris, Ha; Grünwald, V; Petrylak, D; Vaishampayan, U; Gez, E; De Giorgi, U; Lee, Jl; Voortman, J; Gupta, S; Sharma, S; Mortazavi, A; Vaughn, Dj; Isaacs, R; Parker, K; Chen, X; Yu, K; Porter, D; Graus Porta, D; Bajorin, Df.
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
2014-01-01 Conteduca, V; Burgio, Sl; Menna, C; Carretta, E; Rossi, L; Bianchi, E; Masini, C; Amadori, D; De Giorgi, U
Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
2009-01-01 Mego, M; De Giorgi, U; Broglio, K; Dawood, S; Valero, V; Andreopoulou, E; Handy, B; Reuben, Jm; Cristofanilli, M
Systemic immune-inflammation index predicts the clinical outcome in patients with mCRPC treated with abiraterone
2016-01-01 Lolli, C; Caffo, O; Scarpi, E; Aieta, M; Conteduca, V; Maines, F; Bianchi, E; Massari, F; Veccia, A; Chiuri, Ve; Facchini, G; De Giorgi, U
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
2018-01-01 Bravaccini, S; Puccetti, M; Bocchini, M; Ravaioli, S; Celli, M; Scarpi, E; De Giorgi, U; Tumedei, Mm; Raulli, G; Cardinale, L; Paganelli, G
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer
2019-01-01 Pignata, S.; Scambia, G.; Lorusso, D.; De Giorgi, U.; Nicoletto, M. O.; Lauria, R.; Mosconi, A. M.; Sacco, C.; Omarini, C.; Tagliaferri, P.; Ferrandina, G.; Cinieri, S.; Savarese, A.; Valabrega, G.; Pisano, C.; Salutari, V.; Raspagliesi, F.; Kopf, B.; Cecere, S. C.; Amadio, G.; Maltese, G.; Di Napoli, M.; Greggi, S.; Signoriello, S.; Daniele, G.; Sacco, A.; Losito, S.; Normanno, N.; Perrone, F.; Gallo, C.; Piccirillo, M. C.
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study
2019-01-01 Bergamini, A.; Cormio, G.; Ferrandina, G.; Lorusso, D.; Giorda, G.; Scarfone, G.; Bocciolone, L.; Raspagliesi, F.; Tateo, S.; Cassani, C.; Savarese, A.; Breda, E.; De Giorgi, Ugo Federico Francesco; Mascilini, F.; Candiani, M.; Kardhashi, A.; Biglia, N.; Perrone, A. M.; Pignata, S.; Mangili, G.
Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management
2019-01-01 Casadei, C.; Schepisi, G.; Menna, C.; Chovanec, M.; Gurioli, G.; Galla, V.; Altavilla, A.; Marcellini, M.; Bellia, S. R.; Lolli, C.; Mego, M.; Rosti, G.; De Giorgi, U.
Early use of abiraterone and radium-223 in metastatic prostate cancer
2019-01-01 Cursano, M. C.; Santini, D.; Iuliani, M.; Paganelli, G.; De Giorgi, U.
Systemic immune-inflammation index in germ-cell tumours
2018-01-01 Chovanec, M; Cierna, Z; Miskovska, V; Machalekova, K; Kalavska, K; Rejlekova, K; Svetlovska, D; Macak, D; Spanik, S; Kajo, K; Babal, P; De Giorgi, U; Mego, M; Mardiak, J
Sexual functions after high-dose chemotherapy in survivors of germ cell tumors
2003-01-01 Monti, M; Rosti, G; De Giorgi, U; Cavallari, G; Severini, G; Giovanis, P; Marangolo, M.
Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor
2006-01-01 De Giorgi, U; Rosti, G; Aieta, M; Testore, F; Burattini, L; Fornarini, G; Naglieri, E; Lo Re, G; Zumaglini, F; Marangolo, M.
Persistent neutrophil to lymphocyte ratio >3 during treatment with enzalutamide and clinical outcome in patients with castration-resistant prostate cancer
2016-01-01 Conteduca, V; Crabb, Sj; Jones, Rj; Caffo, O; Elliott, T; Scarpi, E; Fabbri, P; Derosa, L; Massari, F; Numico, G; Zarif, S; Hanna, C; Maines, F; Joyce, H; Lolli, C; De Giorgi, U
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators
2018-01-01 Boustani, J; Bertaut, A; Galsky, Md; Rosenberg, Je; Bellmunt, J; Powles, T; Recine, F; Harshman, Lc; Chowdhury, S; Niegisch, G; Yu, Ey; Pal, Sk; De Giorgi, U; Crabb, Sj; Caubet, M; Balssa, L; Milowsky, Mi; Ladoire, S; Créhange, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma | 1-gen-2015 | Santoni, M; Conti, A; Porta, C; Procopio, G; Sternberg, Cn; Basso, U; De Giorgi, U; Bracarda, S; Rizzo, M; Ortega, C; Massari, F; Iacovelli, R; Derosa, L; Masini, C; Milella, M; Di Lorenzo, G; Atzori, F; Pagano, M; Buti, S; De Vivo, R; Mosca, A; Rossi, M; Paglino, C; Verzoni, E; Cerbone, L; Muzzonigro, G; Falconi, M; Montironi, R; Burattini, L; Santini, D; Cascinu, S. | |
| Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide | 1-gen-2019 | Lolli, C.; De Lisi, D.; Conteduca, V.; Gurioli, G.; Scarpi, E.; Schepisi, G.; Ravaglia, G.; Menna, C.; Farolfi, A.; Altavilla, A.; Burgio, S. L.; Tonini, G.; Santini, D.; De Giorgi, U. | |
| Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone | 1-gen-2014 | De Giorgi, U; Caroli, P; Burgio, Sl; Menna, C; Conteduca, V; Bianchi, E; Fabbri, F; Carretta, E; Amadori, D; Paganelli, G; Matteucci, F. | |
| High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party | 1-gen-2007 | De Giorgi, U; Blaise, D; Lange, A; Viens, P; Marangolo, M; Madroszyk, A; Brune, M; Afanassiev, Bv; Rosti, G; Demirer, T. | |
| Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study | 1-gen-2017 | Oing, C; Oechsle, K; Necchi, A; Loriot, Y; De Giorgi, U; Fléchon, A; Daugaard, G; Fedyanin, M; Faré, E; Bokemeyer, C. | |
| Prevention and therapy of neutropenia in elderly patients | 1-gen-2003 | Rosti, G; Kopf, B; Cariello, A; Monti, M; Dazzi, C; Papiani, G; Giovanis, P; De Giorgi, U; Marangolo, M. | |
| Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations | 1-gen-2018 | Pal, Sk; Rosenberg, Je; Hoffman-Censits, Jh; Berger, R; Quinn, Di; Galsky, Md; Wolf, J; Dittrich, C; Keam, B; Delord, Jp; Schellens, Jhm; Gravis, G; Medioni, J; Maroto, P; Sriuranpong, V; Charoentum, C; Burris, Ha; Grünwald, V; Petrylak, D; Vaishampayan, U; Gez, E; De Giorgi, U; Lee, Jl; Voortman, J; Gupta, S; Sharma, S; Mortazavi, A; Vaughn, Dj; Isaacs, R; Parker, K; Chen, X; Yu, K; Porter, D; Graus Porta, D; Bajorin, Df. | |
| Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide | 1-gen-2014 | Conteduca, V; Burgio, Sl; Menna, C; Carretta, E; Rossi, L; Bianchi, E; Masini, C; Amadori, D; De Giorgi, U | |
| Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients | 1-gen-2009 | Mego, M; De Giorgi, U; Broglio, K; Dawood, S; Valero, V; Andreopoulou, E; Handy, B; Reuben, Jm; Cristofanilli, M | |
| Systemic immune-inflammation index predicts the clinical outcome in patients with mCRPC treated with abiraterone | 1-gen-2016 | Lolli, C; Caffo, O; Scarpi, E; Aieta, M; Conteduca, V; Maines, F; Bianchi, E; Massari, F; Veccia, A; Chiuri, Ve; Facchini, G; De Giorgi, U | |
| PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis | 1-gen-2018 | Bravaccini, S; Puccetti, M; Bocchini, M; Ravaioli, S; Celli, M; Scarpi, E; De Giorgi, U; Tumedei, Mm; Raulli, G; Cardinale, L; Paganelli, G | |
| The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer | 1-gen-2019 | Pignata, S.; Scambia, G.; Lorusso, D.; De Giorgi, U.; Nicoletto, M. O.; Lauria, R.; Mosconi, A. M.; Sacco, C.; Omarini, C.; Tagliaferri, P.; Ferrandina, G.; Cinieri, S.; Savarese, A.; Valabrega, G.; Pisano, C.; Salutari, V.; Raspagliesi, F.; Kopf, B.; Cecere, S. C.; Amadio, G.; Maltese, G.; Di Napoli, M.; Greggi, S.; Signoriello, S.; Daniele, G.; Sacco, A.; Losito, S.; Normanno, N.; Perrone, F.; Gallo, C.; Piccirillo, M. C. | |
| Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study | 1-gen-2019 | Bergamini, A.; Cormio, G.; Ferrandina, G.; Lorusso, D.; Giorda, G.; Scarfone, G.; Bocciolone, L.; Raspagliesi, F.; Tateo, S.; Cassani, C.; Savarese, A.; Breda, E.; De Giorgi, Ugo Federico Francesco; Mascilini, F.; Candiani, M.; Kardhashi, A.; Biglia, N.; Perrone, A. M.; Pignata, S.; Mangili, G. | |
| Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management | 1-gen-2019 | Casadei, C.; Schepisi, G.; Menna, C.; Chovanec, M.; Gurioli, G.; Galla, V.; Altavilla, A.; Marcellini, M.; Bellia, S. R.; Lolli, C.; Mego, M.; Rosti, G.; De Giorgi, U. | |
| Early use of abiraterone and radium-223 in metastatic prostate cancer | 1-gen-2019 | Cursano, M. C.; Santini, D.; Iuliani, M.; Paganelli, G.; De Giorgi, U. | |
| Systemic immune-inflammation index in germ-cell tumours | 1-gen-2018 | Chovanec, M; Cierna, Z; Miskovska, V; Machalekova, K; Kalavska, K; Rejlekova, K; Svetlovska, D; Macak, D; Spanik, S; Kajo, K; Babal, P; De Giorgi, U; Mego, M; Mardiak, J | |
| Sexual functions after high-dose chemotherapy in survivors of germ cell tumors | 1-gen-2003 | Monti, M; Rosti, G; De Giorgi, U; Cavallari, G; Severini, G; Giovanis, P; Marangolo, M. | |
| Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor | 1-gen-2006 | De Giorgi, U; Rosti, G; Aieta, M; Testore, F; Burattini, L; Fornarini, G; Naglieri, E; Lo Re, G; Zumaglini, F; Marangolo, M. | |
| Persistent neutrophil to lymphocyte ratio >3 during treatment with enzalutamide and clinical outcome in patients with castration-resistant prostate cancer | 1-gen-2016 | Conteduca, V; Crabb, Sj; Jones, Rj; Caffo, O; Elliott, T; Scarpi, E; Fabbri, P; Derosa, L; Massari, F; Numico, G; Zarif, S; Hanna, C; Maines, F; Joyce, H; Lolli, C; De Giorgi, U | |
| Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators | 1-gen-2018 | Boustani, J; Bertaut, A; Galsky, Md; Rosenberg, Je; Bellmunt, J; Powles, T; Recine, F; Harshman, Lc; Chowdhury, S; Niegisch, G; Yu, Ey; Pal, Sk; De Giorgi, U; Crabb, Sj; Caubet, M; Balssa, L; Milowsky, Mi; Ladoire, S; Créhange, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 03 Articolo su Rivista38605
Data di pubblicazione
- In corso di stampa43
- 2020 - 202710433
- 2010 - 201913552
- 2000 - 20098692
- 1990 - 19993962
- 1980 - 19891442
- 1970 - 1979447
- 1961 - 196934
Editore
- Elsevier BV:PO Box 211, 1000 AE A...454
- American Institute of Physics:2 H...272
- Giuffre Editore Spa:via Busto Ars...128
- Elsevier Science Limited:Oxford F...99
- Congedo Editore Luogo pubbl. Gal...72
- IOP Publishing Limited:Dirac Hous...71
- Springer Verlag Germany:Tiergarte...71
- Kluwer Academic Publishers:Journa...54
- IEEE / Institute of Electrical an...47
- Societa Editrice il Mulino Spa:St...43
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS481
- THE EUROPEAN PHYSICAL JOURNAL. C,...393
- PHYSICS LETTERS. SECTION B392
- PHYSICAL REVIEW LETTERS211
- APPLIED PHYSICS LETTERS186
- NUCLEAR INSTRUMENTS AND METHODS I...185
- THE ASTROPHYSICAL JOURNAL180
- PHYSICAL REVIEW D, PARTICLES, FIE...156
- PHYSICAL REVIEW D148
- ITINERARI DI RICERCA STORICA140
Keyword
- ATLAS1158
- LHC1151
- High Energy Physics1130
- Humans376
- Mediterranean Sea185
- Italy177
- Female144
- Animals143
- Male127
- Hadron-Hadron Scattering122
Lingua
- eng25985
- ita9002
- fre415
- spa191
- ger146
- por94
- lat51
- grc47
- rus43
- chi13
Accesso al fulltext
- no fulltext32279
- open4081
- restricted1185
- reserved1012
- partially open32
- mixed10
- embargoed6